600276 · Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

47.74

CNY

-1.76 (-3.556%)

21/08/2026 12:00:00 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Yuan326.75B

50.20

EV/EBITDA

38.9

DIV Yield

0.4%

Payout Ratio

18%

MQV Rating

3Neutral

As at 21/08/2026 12:00:00 AM

Price Chart

Description

Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. Its products include tablets, oral solution, and suspension of antineoplastic drugs and narcotic drugs, psychotropic substances, soft capsules, freeze-dried powder injection, powder injection, high-volume injection including multi-layer co-extruded infusion bag with anti-tumor drugs, small volume injections including antineoplastic drugs, psychotropic drugs, and non-final sterilization, biological engineering products such as polyethylene glycol recombinant human granulocyte stimulating factor injection, hard capsules, granules, powder, and film and gel. The company was founded in 1970 and is headquartered in Lianyungang, China.

All-Companies
All-Consensus
ALL-Recommendations
Consensus Cheap
HALO 100
HALO 200
HALO All
HALO Balance Sheet
Recent Price downgrade
Short Term Trend - Short
Volume Spike

Key Fundamentals

EPS 3 yr Growth

93.40%

EBITDA Margin

28.50%

Operating Cashflow

¥11,287m

Free Cash Flow Return

21.10%

ROIC

14.40%

Interest Coverage

594.80

Quick Ratio

7.60

Performance

52 weeks range

Low 45.26 - 74.04

Trade Value (12mth)

US$137,772,652.00

1 week

-7.92%

1 month

-9.85%

YTD

-21.53%

1 year

-18.84%

All time high

97.39

Additional Data

Shares Outstanding (Fully Diluted)

6,601m

HALO Sector

Healthcare

Next Company Report Date

19-Apr-27

Next Ex Dividend Date

27-May-26

Next Dividend Pay Date

27-May-26

Reporting Currency

CNY

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Weak

Event

Very Strong

Halo Model

Mqv

Neutral

Garp

Neutral

Mqv Small

Neutral

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

Date	Event
21 August 25Flash
25 October 24Flash
25 September 24Flash

Key Stakeholders

Name	Title
Piao Yang Sun	Individual
Tibet Dazi Dayuan Business Management Co. Ltd.	Private Company
China State-Owned Assets Supervision & Admn Commission	Government
Qingdao Bosentai Technology Co. Ltd.	Private Company
City of Lianyungang	Government